Maria Cristina Nieto GarciaNational Institute of Health Carlos III (ISCIII), ERA PerMed coordinator
ERA PerMed
National Health School, ISCIII, Madrid, Spain, 6-7th Nov 2019
Cluster event on Personalised Medicine with ITN funded projects
GRANT AGREEMENTNUMBER — 779282 ERA PerMed
Horizon 2020
ERA PerMed
JTC2018 (co-funded by EC)
JTC2019
Next calls: JTC2020 & JTC2021
ERAPerMed – Content
ERAPerMed – Characteristics
32 Partners23 Countries
19 EU countries3 associated countries (to Horizon 2020)Turkey, Norway, Israel1 third country (Canada)
5 regions; Saxony, Quebec, Lombardy, Navarra and Cataluña
Coordination:Instituto de Salud Carlos III(ISCIII), SPAIN
MAIN OBJECTIVES
1 EU Co-funded Call 2018
Joint Transnational Calls (JTCs)
Up to 3 Additional Calls 2019, 2020, 2021
TIME FRAME: 1 December 2017 – 30 November 2022
The biggest ERA Net in health
http://www.erapermed.eu/
Horizon 2020Call: H2020-SC1-2016-2017
(Personalised Medicine)Topic: SC1-HCO-03-2017
Foster the implementation of ICPerMed Action Plan and SRIA (Strategic Research and Innovation Agenda) by funding transnational research projects in the field of Personalised Medicine (PM)
Alignment of regional and national PM research strategies and funding activities, promoting excellence, reinforcing the competitiveness of Europe and Canada and enhance the European collaboration as well as with countries beyond the European Union.
Action Plan SRIA
https://www.icpermed.eu/
Definition of Personalised Medicine:
Stated in the Strategic Research and Innovation Agenda(SRIA) of PerMed, adopted from the H2020 advisory group*:
• “Personalised Medicine refers to a medical model usingcharacterisation of individuals’ phenotypes and genotypes(e.g. molecular profiling, medical imaging, lifestyle data) fortailoring the right therapeutic strategy for the right person atthe right time, and/or to determine the predisposition todisease and/or to deliver timely and targeted prevention.”
* European Commission. Advice for 2016/2017 of the Horizon 2020 Advisory Group for Social
Challenge 1, “Health, Demographic Change and Wellbeing
ERAPerMed
WP1 - COORDINATION & MANAGEMENT
EC cofunded callWP2+WP3+WP4+WP5
WP6 - ADDITIONAL NON COFUNDED CALLS
WP 7 - STRATEGIC SUPPORT ACTIVITIESExternal relationships, relationship with end users and patient
representatives, sustainability and exploitation of results…
ERAPerMed – Structure
WP 2 - PREPARATION AND LAUNCH OF THE EU CO-FUNDED CALL
WP 3 – EVALUATION & PROPOSAL SELECTION OF THE EU CO-FUNDED CALL
WP 4 - FOLLOW UP AND MONITORING OF THE EU CO-FUNDED PROJECTS
WP 5 - COMMUNICATION AND EXPLOITATION OF RESULTS OF THE EU CO-FUNDED CALL
ERAPerMed – Structure
EC cofunded call
ERA PerMed – cofunding scheme
7,834,200 €33% of the budget
commitment 1,674,750 €
9,508,950 € Maximum EU contribution
Unitcosts
2,790,337 €6,718,613 €EC cofundedcall
Implementation costs
23,740,000 €
Initial Financial Commitment of ERA PerMed Partners
ERA PerMed
JTC2018 (co-funded by EC)
JTC2019
Next calls: JTC2020 & JTC2021
ERAPerMed – Content
ERAPerMed – EU co-funded JTC 2018
30 Partners22 Countries
19 EU countries3 associated countries (to Horizon 2020):
Turkey, Norway, Israel
1 third country: Canada
5 regions
Call Secretariat (JCS)Instituto de Salud Carlos III (ISCIII), SPAIN
Countries´ ex ante Budget 26 M €
Timeline:
Launch: 14th February 2018
Two step procedure
Submission deadline for Pre-proposals: 10th April 2018
Submission deadline for invited Full-proposals: 26th July 2018Expected start of granted projects: 2019 q1
http://www.erapermed.eu/joint-calls/joint-transnational-call-2018/
Call calendar
Preparation of the JTC2018
JTC2018
December February April June July August
Pre-announcement
Launch
Submission deadline
pre-proposals
CSC meeting
Submissiondeadline
full-proposals
Final funding decision in November 2018
Evaluation 1st stage
Rebuttal phase
Evaluation 2nd stage
September
PRP meeting
20182017
April June July August September December
First conceptExpert
consultationFirst draft of the call text
CAB response on the call text
(Pre-) Final version of the call text
Validation of the call text by
the ECAt least 30 days
before launching
2017
November
Survey on participation /
advanced concept
At least 60 days
Each proposal is allocated to 3 Peer Reviewers for evaluation.
TOPIC: RESEARCH PROJECTS ON PERSONALISED MEDICINE – SMART COMBINATION OF
PRE-CLINICAL AND CLINICAL RESEARCH WITH DATA AND ICT SOLUTIONS
ERAPerMed – EU co-funded JTC 2018
Scope of the call
Each project proposal MUST address at least one module of both Research Areas 1 and 2.
Central Eligibility
A) Academia or research institutes;
B) Clinical/public health sector
C) (Industry) Private partners, e.g. SMEs
• Each consortium must involve at least 3 partners eligible
for funding coming from 3 different countries.
• Project coordinator must be eligible to be funded
• The maximum number of partners per project is 6
(7 if underrepresented)
• No more than two partners from the same country.
• No more than one partner with its own funding is allowed.
* Each FO has its own national/regional eligibility criteria
ERA PerMed JTC 2018
Partnering Tool
https://partnering.pt-dlr.de/ICPerMed
ERAPerMed – EU co-funded JTC 2018
Pre-proposal Coordinators and Partners per Country
ERAPerMed – EU co-funded JTC 2018
Pre-proposal Request of Funding per Country
ERAPerMed – EU co-funded JTC 2018
Type of Applicant Beneficiary Entity in Pre-proposals
ERAPerMed – EU co-funded JTC 2018
ERAPerMed – EU co-funded JTC 2018 Facts and Figures
• Pre-proposal stage:
• 159/143 submitted projects
• 741 partners requesting to 30 funding organisations
• 176.21 M € requested funding
• 50 Pre-proposals invited to submit a Full proposal
• 75 evaluators from institutions affiliated to 24 countries (25% females)
• Full proposal stage:
• 50 submitted projects
• 25 Proposals funded, 131 partners requesting to 21 funding organisations.
• 28.27 M € requested funding
• 23 evaluators from institutions affiliated to 15 countries
ERA PerMed
JTC2018 (co-funded by EC)
JTC2019
Next calls: JTC2020 & JTC2021
ERAPerMed – Content
30 Partners22 Countries
17 EU countries3 associated countries (to Horizon 2020):
Turkey, Norway, Israel
2 third countries: Canada and Egypt
6 regions (Saxony, Quebec, Lombardy,
Navarra ,Cataluña and Tuscany
1 charity: AECC
Call Secretariat (JCS)Agence National de la Recherche (ANR)FRANCE Countries´ ex ante Budget
31.42 M €Two step procedure
Timeline:
Launch: 9th January 2019Submission deadline for Pre-proposals: 7th March 2019
Submission deadline for invited Full-proposals: 17th June 2019
http://www.erapermed.eu/joint-transnational-call-2019/
ERAPerMed – non EU co-funded JTC 2019
ERAPerMed – non EU co-funded JTC 2019
Scope of the call
TOPIC: PERSONALIZED MEDICINE: MULTIDISCIPLINARY RESEARCH TOWARDS IMPLEMENTATION
Each project proposal MUST address at least one module of Research Area 3 and at least one module of Research Area 1 or 2.
Submitted pre-proposals – N° partners/coordinators
4
3
5
7
8
7
8
9
11
10
13
11
14
10
17
17
16
27
26
25
21
26
34
34
33
27
49
43
39
86
97
0
2
1
1
0
1
2
2
2
3
1
4
1
7
2
3
9
0
2
3
13
10
4
6
15
23
3
15
25
14
22
0 20 40 60 80 100 120
CDTI
ASRT
FNR
FRQS
TUBITAK
VIAA
MSE
F.R.S.-FNRS
BMG/VDI
TuscReg
HRB
GN
NKFIH
SMWK
CIHR
RCN
CSO-MOH
no funding request
InnoFond
NCBR
AKA
UEFISCDI
DS-CAT
FWF
ISCIII/AECC-FC
IT-MoH
SRC
GSRT
FRRB
ANR
BMBF/DLR
Partner
Coordinator
Submitted pre-proposals – budget requested
38840 483,00 €
24578 937,00 €
18174 737,00 €
16544 040,00 €
11104 420,00 €
10384 314,00 €
9917 828,00 €
9168 782,00 €
8608 192,00 €
7636 561,00 €
7262 921,00 €
6624 952,00 €
5866 548,00 €
5109 993,00 €
4322 676,00 €
3616 365,00 €
3588 005,00 €
3442 102,00 €
3401 977,00 €
3121 934,00 €
2357 042,00 €
2205 592,00 €
2066 203,00 €
1908 913,00 €
1655 437,00 €
1455 347,00 €
1199 175,00 €
939 300,00 €
823 802,00 €
567 000,00 €
0,00 € 5000 000,00 € 10000 000,00 € 15000 000,00 € 20000 000,00 € 25000 000,00 € 30000 000,00 € 35000 000,00 € 40000 000,00 € 45000 000,00 €
BMBF/DLR
ANR
FRRB
SRC
IT-MoH
FWF
GSRT
InnoFond
ISCIII/AECC-FC
AKA
DS-CAT
SMWK
UEFISCDI
RCN
NCBR
CIHR
CSO-MOH
HRB
BMG/VDI
GN
TuscReg
FRQS
NKFIH
F.R.S.-FNRS
FNR
VIAA
MSE
TUBITAK
CDTI
ASRT
ERAPerMed –non EU co-funded JTC 2019 Facts and Figures
• Pre-proposal stage:
• 196 submitted projects
• 906 partners requesting to 30 funding organisations (27 own funding)
• 216 M € requested funding
• 56 Pre-proposals invited to submit a Full proposal
• 102 evaluators from institutions affiliated to 26 countries (33% females)
• Full proposal stage:
• 56 submitted projects
• 22 Proposals expected to be funded, 108 partners requesting to 24
funding organisations (5 partners on own funding).
• 24.6 M € requested funding
• 29 evaluators from institutions affiliated to 17 countries
ERA PerMed
JTC2018 (co-funded by EC)
JTC2019
Next calls: JTC2020 & JTC2021
ERAPerMed – Content
31 Partners 22 Countries
17 EU countries2 associated countries (to Horizon 2020):Norway, Israel3 third countries: Canada, Egypt, Panama6 regions (Saxony, Quebec, Lombardy,
Navarra, Cataluña and Tuscany)1 charity: AECC
Call Secretariat (JCS)
German Aerospace Center (DLR)GERMANY [email protected] Countries´ ex ante Budget
24.6 M € approx.
Two step procedure
Timeline expected:
Launch: December 2019Submission deadline for Pre-proposals: March 2020
Submission deadline for invited Full-proposals: June 2020
ERAPerMed – non EU co-funded JTC 2020
http://www.erapermed.eu/wp-content/uploads/2019/11/ERA-PerMed_JTC2020_pre-announcement_final.pdf
ERAPerMed – non EU co-funded JTC 2020
Scope of the call
TOPIC: “PERSONALISED MEDICINE – PRE-/CLINICAL RESEARCH, BIG DATA AND ICT, IMPLEMENTATION AND USER’S PERSPECTIVE”
Each project proposal MUST address at least one module of Research Area 3 and at least one module of Research Area 1 or 2.
JCS2018: ISCIII- Mauricio García, Candi Sánchez and Cristina Nieto:
JCS2019: ANR- Monika Frenzel and Jeanne Guihot
JCS2020: DLR- Katja Kuhlmann and Alexandra Becker
ERAPerMed – Joint Call Secretariat contact points
Thank you for your attention!
Contact: Maria Cristina Nieto Garcia, PhD <[email protected]>
GRANT AGREEMENTNUMBER — 779282 ERA PerMed
Horizon 2020